Primary Record
DIAVERIDINE
Note: Only for scientific research or as raw materials for production.
- In stock
- 902 g
- Purity
- 98.2 %
- CAS
- 5355-16-8
Compound Identifiers & Properties
- CAS
- 5355-16-8
- PubChem CID
- 21453
- SMILES
- COC1=C(C=C(C=C1)CC2=CN=C(N=C2N)N)OC
- Canonical SMILES
- COc1ccc(Cc2cnc(N)nc2N)cc1OC
Names & Synonyms
- DIAVERIDINE
- Diaveridin
- Diaveridinum
- Diaveridina
- 5355-16-8
- 2,4-Diamino-5-veratrylpyrimidine
- 5-(3,4-dimethoxybenzyl)pyrimidine-2,4-diamine
- Diaveridinum [INN-Latin]
- Diaveridina [INN-Spanish]
- Diaveridine (Standard)
- EGIS-5645
- BW 49-210
- Diaveridine < Rec INN
- C13H16N4O2
- AC1L2ICY
- AC1Q4CFM
- DIAVERIDINE [MI]
- Diaveridine [USAN:INN:BAN]
- RefChem:586320
- 7KVX81XA87
- CCRIS 3784
- DIAVERIDINE [INN]
- UNII-7KVX81XA87
- Diaveridine (USAN/INN)
- NSC-408735
- DIAVERIDINE [USAN]
- DTXSID2046200
- CHEMBL19633
- D0FC5T
- Epitope ID:119685
- 5-[(3,4-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine
- EGIS 5645
- 2,4-Diamino-5-(3,4-dimethoxybenzyl)pyrimidine
- CHEBI:123115
- LDBTVAXGKYIFHO-UHFFFAOYSA-N
- DIAVERIDINE [MART.]
- SCHEMBL93896
- DIAVERIDINE [USP-RS]
- DTXCID0026200
- MLS004712092
- orb321035
- Pyrimidine, 2,4-diamino-5-veratryl-
- EINECS 226-333-3
- 2,4-dimethoxybenzyl)pyrimidine
- Diaveridine [USAN:BAN:INN]
- AI3-23935
- orb1306113
- Diaveridine, 98% - 1G 1g
- NSC 408735
- SCHEMBL29527560
- CTK8F9123
- HY-B1902R
- ZINC24946
- BRN 0258464
- MFCD00057349
- NSC408735
- Pyrimidine,4-diamino-5-veratryl-
- s5200
- BW-49210
- HMS3264I16
- HMS5084B13
- Pharmakon1600-01502300
- 5-((3,4-Dimethoxyphenyl)methyl)-2,4-pyrimidinediamine
- CID21453
- HY-B1902
- MSK21042
- BW-49-210
- Tox21_111866
- BBL009897
- BDBM50138691
- EBC-07775
- NCGC00160517-01
- NP3701
- NSC759634
- STK711076
- 5-(3,4-Dimethoxybenzyl)-2,4-pyrimidinediamine
- Diaveridine 10 microg/mL in Acetonitrile
- AKOS005530708
- C13-H16-N4-O2
- Tox21_111866_1
- C(c1ccc(OC)c(OC)c1)c2cnc(N)nc2N
- CCG-213021
- CS-O-11990
- FD66116
- J9.549D
- NSC-759634
- VA10713
- 2, 5-[(3,4-dimethoxyphenyl)methyl]-
- 2,4-Pyrimidinediamine, 5-[(3,4-dimethoxyphenyl)methyl]-
- NCGC00160517-02
- NCGC00160517-03
- AC-12110
- AJ-08448
- AS-56306
- BW 49210
- P787
- SMR002529995
- ST082353
- ZB000803
- 5-(3,4-Dimethoxy-benzyl)-pyrimidine-2,4-diamine
- CAS-5355-16-8
- 2,4-Pyrimidinediamine, 5-((3,4-dimethoxyphenyl)methyl)-
- 5-(3,4-Dimethoxybenzyl)-2,4-diaminopyrimidine
- LS-134998
- AK00037240
- CS-0013961
- FT-0603089
- NS00000684
- 2,4-Diamino-5-(3',4'-dimethoxybenzyl)pyrimidine
- 5-25-13-00391 (Beilstein Handbook Reference)
- 210U49
- D03771
- D81857
- AB01562957_01
- Diaveridine, VETRANAL(TM), analytical standard
- EN300-7440332
- 355D168
- 5-(3,4-Dimethoxybenzyl)-2,4-pyrimidinediamine #
- 5-[(3,4-Dimethoxyphenyl)methyl]-2,4-pyrimidinediamine
- A829660
- SR-01000939849
- 2,4-diamino-5-(3',4'-dimethoxybenzyl) pyrimidine
- 2,4-diamino-5-(3',4'-dimethoxybenzyl)-pyrimidine
- Diaveridine, analytical standard, >=99.0% (TLC)
- SR-01000939849-2
- BRD-K97464279-001-03-5
- Q27212503
- Z2681892420
- 5-[(3,4-Dimethoxyphenyl)methyl]-2,4-pyrimidine- diamine HCl
- Diaveridine, United States Pharmacopeia (USP) Reference Standard
- 2,4-Pyrimidinediamine, 5-[(3,4-dimethoxyphenyl)methyl]-; yrimidine, 2,4-diamino-5-veratryl- (6CI,7CI,8CI); 2,4-Diamino-5-(3,4-dimethoxybenzyl)pyrimidine; 2,4-Diamino-5-veratrylpyrimidine; BW 49-210; Diaveridin; Diaveridine; EGIS 5645; NSC 408735
- 226-333-3
- 2507-23-5
- BAN
- KUP